Post Market Clinical Follow-up Study Protocol for DYNASTY® BioFoam® Acetabular Components
Sponsor: MicroPort Orthopedics Inc.
Listed as NCT02149667, this observational or N/A phase trial focuses on Joint Disease and remains ongoing. Sponsored by MicroPort Orthopedics Inc., it has been updated 13 times since 2014, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
-
Jul 2023 — Jul 2024 [monthly]
Active Not Recruiting
-
May 2023 — Jul 2023 [monthly]
Active Not Recruiting
-
May 2022 — May 2023 [monthly]
Active Not Recruiting
Status: Enrolling By Invitation → Active Not Recruiting
▶ Show 8 earlier versions
-
May 2021 — May 2022 [monthly]
Enrolling By Invitation
-
Jan 2021 — May 2021 [monthly]
Enrolling By Invitation
-
May 2020 — Jan 2021 [monthly]
Enrolling By Invitation
-
Jun 2019 — May 2020 [monthly]
Enrolling By Invitation
-
Jul 2018 — Jun 2019 [monthly]
Enrolling By Invitation
-
Jun 2018 — Jul 2018 [monthly]
Enrolling By Invitation
-
Apr 2018 — Jun 2018 [monthly]
Enrolling By Invitation
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Enrolling By Invitation NA
First recorded
Dec 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- MicroPort Orthopedics Inc.
For direct contact, visit the study record on ClinicalTrials.gov .